- Home
- YYGH vs OPTN Comparison
YYGH vs OPTN Comparison
Compare YYGH & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YYGH
- OPTN
- Stock Information
- Founded
- YYGH 2010
- OPTN 2010
- Country
- YYGH Singapore
- OPTN United States
- Employees
- YYGH N/A
- OPTN N/A
- Industry
- YYGH
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- YYGH
- OPTN Health Care
- Exchange
- YYGH NYSE
- OPTN Nasdaq
- Market Cap
- YYGH 69.2M
- OPTN 55.4M
- IPO Year
- YYGH 2024
- OPTN 2017
- Fundamental
- Price
- YYGH $1.13
- OPTN $9.17
- Analyst Decision
- YYGH
- OPTN Hold
- Analyst Count
- YYGH 0
- OPTN 3
- Target Price
- YYGH N/A
- OPTN $9.00
- AVG Volume (30 Days)
- YYGH 88.5K
- OPTN 141.6K
- Earning Date
- YYGH 04-29-2025
- OPTN 05-13-2025
- Dividend Yield
- YYGH N/A
- OPTN N/A
- EPS Growth
- YYGH N/A
- OPTN N/A
- EPS
- YYGH N/A
- OPTN N/A
- Revenue
- YYGH $41,103,389.00
- OPTN $78,226,000.00
- Revenue This Year
- YYGH N/A
- OPTN $30.49
- Revenue Next Year
- YYGH N/A
- OPTN $13.51
- P/E Ratio
- YYGH N/A
- OPTN N/A
- Revenue Growth
- YYGH 29.37
- OPTN 10.20
- 52 Week Low
- YYGH $0.72
- OPTN $4.82
- 52 Week High
- YYGH $4.70
- OPTN $20.03
- Technical
- Relative Strength Index (RSI)
- YYGH N/A
- OPTN 76.77
- Support Level
- YYGH N/A
- OPTN $8.75
- Resistance Level
- YYGH N/A
- OPTN $9.28
- Average True Range (ATR)
- YYGH 0.00
- OPTN 0.14
- MACD
- YYGH 0.00
- OPTN -0.11
- Stochastic Oscillator
- YYGH 0.00
- OPTN 79.25
About YYGH YY GROUP HOLDING LIMITED
YY Group Holding Ltd is a data and technology driven company focused on developing enterprise intelligent labor matching services and smart cleaning services founded in Singapore. It provides enterprise manpower outsourcing and smart cleaning services in Singapore and Malaysia. The group has two operating segment, which is cleaning services segment and manpower outsourcing services, Maximum revenue is generated from cleaning services.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.